Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy.

Abstract

Authors

• Xuewei Wu
  Department of Radiology, the First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
• Jingjing You
  Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
• Shuixing Zhang
  Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, PR China; Institute of Molecular and Functional Imaging, Jinan University, Guangzhou, Guangdong, PR China. Electronic address: shui7515@126.com.
• Bin Zhang
  Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Keywords

External Resources